Functionality of sequence variants in the genes coding for the low-density lipoprotein receptor and apolipoprotein B in individuals with inherited hypercholesterolemia
Open Access
- 13 April 2010
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 31 (6), 752-760
- https://doi.org/10.1002/humu.21258
Abstract
Patients with familial hypercholesterolemia (FH) have elevated LDL-C levels, usually above the 90th percentile (P90) for age and gender. However, large-scale genetic cascade screening for FH showed that 15% of the LDL-receptor (LDLR) or Apolipoprotein B (APOB) mutation carriers have LDL-C levels below P75. Nonpathogenicity of sequence changes may explain this phenomenon. To assess pathogenicity of a mutation we proposed three criteria: (1) mean LDL-C >P75 in untreated mutation carriers; (2) higher mean LDL-C level in untreated carriers than in untreated noncarriers; and (3) higher percentage of medication users in carriers than in noncarriers at screening. We considered a mutation nonpathogenic when none of the three criteria were met. We applied these criteria to mutations that had been determined in more than 50 untreated adults. Segregation analysis was performed to confirm nonpathogenicity. Forty-six mutations had been tested in more than 50 untreated subjects, and three were nonpathogenic according to our criteria: one in LDLR (c.108C>A, exon 2) and two in APOB (c.13154T>C and c.13181T>C, both in exon 29). Segregation analysis also indicated nonpathogenicity. According to our criteria, three sequence variants were nonpathogenic. The criteria may help to identify nonpathogenic sequence changes in genetic cascade screening programs. Hum Mutat 31:752–760, 2010.This publication has 22 references indexed in Scilit:
- Two Years after Molecular Diagnosis of Familial Hypercholesterolemia: Majority on Cholesterol-Lowering Treatment but a Minority Reaches Treatment GoalPLOS ONE, 2010
- The molecular basis of familial hypercholesterolemia in Lebanon: Spectrum ofLDLRmutations and role ofPCSK9as a modifier geneHuman Mutation, 2009
- Silent exonic mutations in the low‐density lipoprotein receptor gene that cause familial hypercholesterolemia by affecting mRNA splicingClinical Genetics, 2008
- Update of the molecular basis of familial hypercholesterolemia in The NetherlandsHuman Mutation, 2005
- easyLINKAGE-Plus--automated linkage analyses using large-scale SNP dataBioinformatics, 2005
- High frequency of APOB gene mutations causing familial hypobetalipoproteinaemia in patients of Dutch and Spanish descentJournal of Medical Genetics, 2005
- The molecular basis of familial hypercholesterolemia in The NetherlandsHuman Genetics, 2001
- The Molecular Mechanism for the Genetic Disorder Familial Defective Apolipoprotein B100Online Journal of Public Health Informatics, 2001
- Outcome of case finding among relatives of patients with known heterozygous familialBMJ, 2000
- Mutation nomenclature extensions and suggestions to describe complex mutations: A discussionHuman Mutation, 1999